PARIS--(BUSINESS WIRE)--July 17, 2006--BioAlliance Pharma SA(PARIS: BIO - News), an emerging specialty pharmaceutical company focused on the development of innovative therapeutics targeting drug resistance in cancer, HIV, and severe and opportunistic infections, announced today it has made three key appointments which bring substantial experience to BioAlliance. Laure Lagon becomes General Counsel, Delphine Lucas Regulatory Affairs Manager and Aude Michel Intellectual Property Manager.
